Antimelanoma differentiation‐associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis
Matsushita, T. ; Mizumaki, K. ; Kano, M. ; Yagi, N. ; Tennichi, M. ; Takeuchi, A. ; Okamoto, Y. ; Hamaguchi, Y. ; Murakami, A. ; Hasegawa, M. ; Kuwana, M. ; Fujimoto, M. ; Takehara, K.
British journal of dermatology (1951), 2017-02, Vol.176 (2), p.395-402 [Revista revisada por pares]England: Oxford University Press
Texto completo disponible